Deutsche Bank Ag\ Karyopharm Therapeutics Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,268,777 shares of KPTI stock, worth $989,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,268,777

Previous 1,268,777 -0.0%

Holding current value

$989,646

Previous $1.1 Million 4.53%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.87 - $1.58 $48,894 - $88,796	-56,200 Reduced 4.24%	1,268,777 $1.1 Million
Q1 2024 May 15, 2024	SELL	$0.72 - $1.66 $1,462 - $3,371	-2,031 Reduced 0.15%	1,324,977 $2 Million
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.31 $862,768 - $1.66 Million	1,268,777 Added 2178.87%	1,327,008 $1.14 Million
Q3 2023 Nov 09, 2023	SELL	$1.14 - $1.81 $1.75 Million - $2.78 Million	-1,534,953 Reduced 96.34%	58,231 $78,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $4.59 $92,632 - $237,532	-51,750 Reduced 3.15%	1,593,184 $2.85 Million
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $2.98 Million - $4.12 Million	1,050,608 Added 176.77%	1,644,934 $6.4 Million
Q4 2022 Feb 13, 2023	BUY	$2.48 - $5.93 $1,262 - $3,018	509 Added 0.09%	594,326 $2.02 Million
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $2,737 - $3,905	-671 Reduced 0.11%	593,817 $3.24 Million
Q2 2022 Aug 11, 2022	SELL	$4.15 - $8.37 $20,534 - $41,414	-4,948 Reduced 0.83%	594,488 $2.68 Million
Q1 2022 May 13, 2022	BUY	$5.91 - $14.38 $3.26 Million - $7.93 Million	551,470 Added 1149.71%	599,436 $4.42 Million
Q4 2021 Feb 11, 2022	SELL	$5.21 - $8.61 $920,450 - $1.52 Million	-176,670 Reduced 78.65%	47,966 $308,000
Q3 2021 Nov 04, 2021	SELL	$4.45 - $10.63 $9,376 - $22,397	-2,107 Reduced 0.93%	224,636 $1.31 Million
Q2 2021 Aug 11, 2021	SELL	$8.11 - $11.11 $501,279 - $686,709	-61,810 Reduced 21.42%	226,743 $2.34 Million
Q1 2021 May 13, 2021	BUY	$9.85 - $17.69 $1.17 Million - $2.1 Million	118,645 Added 69.83%	288,553 $3.04 Million
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $613,487 - $745,289	43,356 Added 34.26%	169,908 $2.63 Million
Q3 2020 Nov 12, 2020	SELL	$14.14 - $19.71 $1.48 Million - $2.06 Million	-104,454 Reduced 45.22%	126,552 $1.85 Million
Q2 2020 Aug 13, 2020	BUY	$16.6 - $25.25 $1.33 Million - $2.02 Million	80,181 Added 53.16%	231,006 $4.38 Million
Q1 2020 May 14, 2020	BUY	$14.38 - $27.72 $698,796 - $1.35 Million	48,595 Added 47.53%	150,825 $2.9 Million
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $788,749 - $1.68 Million	85,455 Added 509.42%	102,230 $1.96 Million
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $389,730 - $815,955	-68,857 Reduced 80.41%	16,775 $161,000
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $3.56 Million - $5.29 Million	-823,318 Reduced 90.58%	85,632 $511,000
Q1 2019 May 15, 2019	BUY	$4.12 - $10.25 $1.77 Million - $4.4 Million	429,627 Added 89.63%	908,950 $5.31 Million
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $1.09 Million - $2.25 Million	132,753 Added 38.3%	479,323 $4.49 Million
Q3 2018 Dec 21, 2021	BUY	$17.03 - $21.18 $1.35 Million - $1.67 Million	79,011 Added 29.53%	346,570 $5.9 Million
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $1.07 Million - $1.33 Million	-62,896 Reduced 19.03%	267,559 $4.55 Million
Q2 2018 Apr 21, 2020	BUY	$12.0 - $19.88 $305,868 - $506,721	25,489 Added 8.36%	330,455 $5.62 Million
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $1.39 Million - $2.3 Million	115,481 Added 60.94%	304,966 $5.18 Million
Q1 2018 Oct 18, 2019	BUY	$9.92 - $17.25 $357,358 - $621,414	36,024 Added 23.47%	189,485 $2.54 Million
Q1 2018 May 15, 2018	SELL	$9.92 - $17.25 $346,327 - $602,232	-34,912 Reduced 18.53%	153,461 $2.06 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $238,888 - $313,034	26,108 Added 16.09%	188,373 $1.81 Million
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $1.32 Million - $1.81 Million	162,265	162,265 $1.78 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $62.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account